Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Medarex Inc (MEDX) since 2006 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data at Medarex Inc. Table 2 shows the detailed insider transactions. The reporting company's CIK number is 874255.
Total stock buying since 2006: $15,185,475.
Total stock sales since 2006: $142,053,520.
Total stock option exercises since 2006: $3,035,260.
▪ Recent SEC 13D filings for all companies
▪ Recent portfolio reports of all companies
Insider Buying | Insider Sales | Option Exercises | ||||
---|---|---|---|---|---|---|
Year | Shares | Value | Shares | Value | Shares | Value |
2009 | 0 | $0 | 66,117 | $439,039 | 26,120 | $0 |
2008 | 0 | $0 | 50,000 | $446,250 | 340,000 | $967,980 |
2007 | 1,249,200 | $15,185,475 | 8,027,660 | $136,311,391 | 227,608 | $568,760 |
2006 | 0 | $0 | 403,000 | $4,856,840 | 398,000 | $1,498,520 |
Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
---|---|---|---|---|---|---|
year-month | Shares | Value | Shares | Value | Shares | Value |
2009-07 | 0 | $0 | 29,000 | $240,870 | 0 | $0 |
2009-06 | 0 | $0 | 5,000 | $41,650 | 0 | $0 |
2009-04 | 0 | $0 | 13,716 | $71,323 | 0 | $0 |
2009-02 | 0 | $0 | 18,401 | $85,196 | 26,120 | $0 |
2008-04 | 0 | $0 | 0 | $0 | 340,000 | $967,980 |
2008-03 | 0 | $0 | 50,000 | $446,250 | 0 | $0 |
2007-10 | 0 | $0 | 0 | $0 | 30,000 | $81,600 |
2007-08 | 1,249,200 | $15,185,475 | 7,945,070 | $135,324,738 | 0 | $0 |
2007-06 | 0 | $0 | 0 | $0 | 122,000 | $391,010 |
2007-03 | 0 | $0 | 82,590 | $986,653 | 75,608 | $96,150 |
2006-05 | 0 | $0 | 288,000 | $3,258,840 | 258,000 | $732,720 |
2006-04 | 0 | $0 | 0 | $0 | 40,000 | $128,800 |
2006-03 | 0 | $0 | 115,000 | $1,598,000 | 100,000 | $637,000 |
Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2009-07-10 | Pien Howard H (Pres., CEO & Chair. of the Brd) | Sale | 4,000 | 8.38 | 33,520 |
2009-07-09 | Pien Howard H (Pres., CEO & Chair. of the Brd) | Sale | 5,000 | 8.27 | 41,350 |
2009-07-07 | Pien Howard H (Pres., CEO & Chair. of the Brd) | Sale | 5,000 | 8.06 | 40,300 |
2009-07-06 | Pien Howard H (Pres., CEO & Chair. of the Brd) | Sale | 5,000 | 8.24 | 41,200 |
2009-07-02 | Pien Howard H (Pres., CEO & Chair. of the Brd) | Sale | 5,000 | 8.51 | 42,550 |
2009-07-01 | Pien Howard H (Pres., CEO & Chair. of the Brd) | Sale | 5,000 | 8.39 | 41,950 |
2009-06-30 | Pien Howard H (Pres., CEO & Chair. of the Brd) | Sale | 5,000 | 8.33 | 41,650 |
2009-04-03 | Lonberg Nils (Sr. VP, Scientific Director) | Sale | 10,750 | 5.20 | 55,900 |
2009-04-03 | Pepin Ronald (SVP, Bus. Dev.) | Sale | 2,966 | 5.20 | 15,423 |
2009-02-24 | Lonberg Nils (Sr. VP, Scientific Director) | Sale | 14,816 | 4.63 | 68,598 |
2009-02-24 | Lonberg Nils (Sr. VP, Scientific Director) | Option Ex | 14,816 | .00 | 0 |
2009-02-24 | Nichol Geoffrey (Sr. V. P. Product Development) | Option Ex | 5,926 | .00 | 0 |
2009-02-24 | Pepin Ronald (SVP, Bus. Dev.) | Sale | 3,585 | 4.63 | 16,598 |
2009-02-24 | Pepin Ronald (SVP, Bus. Dev.) | Option Ex | 5,378 | .00 | 0 |
2008-04-03 | Lerner Irwin | Option Ex | 204,000 | 2.85 | 580,788 |
2008-03-28 | Schaller Charles R | Sale | 50,000 | 8.93 | 446,250 |
2007-10-01 | Lonberg Nils (Sr. VP, Scientific Director) | Option Ex | 30,000 | 2.72 | 81,600 |
2007-08-08 | Bnp Paribas Securities Corp (10% Owner) | Buy | 1,244,700 | 14.29 | 15,111,450 |
2007-08-08 | Bnp Paribas Securities Corp (10% Owner) | Sale | 3,979,570 | 15.50 | 67,760,549 |
2007-06-15 | Schaller Charles R | Option Ex | 50,000 | 3.21 | 160,250 |
2007-06-14 | Lerner Irwin | Option Ex | 72,000 | 3.21 | 230,760 |
2007-03-20 | Schaller Charles R | Sale | 30,000 | 11.81 | 354,450 |
2007-03-20 | Schaller Charles R | Option Ex | 30,000 | 3.21 | 96,150 |
2007-03-19 | Middlekauff W Bradford (SVP, General Counsel & Sec.) | Sale | 10,878 | 11.87 | 129,143 |
2007-03-16 | Middlekauff W Bradford (SVP, General Counsel & Sec.) | Sale | 5,450 | 11.91 | 64,909 |
2007-03-15 | Vida Julius A | Sale | 15,000 | 12.07 | 181,050 |
2007-03-15 | Lonberg Nils (Sr. VP, Scientific Director) | Sale | 10,000 | 12.10 | 121,000 |
2007-03-15 | Pepin Ronald (SVP, Bus. Dev.) | Sale | 11,262 | 12.09 | 136,101 |
2007-03-02 | Lonberg Nils (Sr. VP, Scientific Director) | Option Ex | 18,018 | .00 | 0 |
2007-03-02 | Pepin Ronald (SVP, Bus. Dev.) | Option Ex | 11,262 | .00 | 0 |
2007-03-02 | Middlekauff W Bradford (SVP, General Counsel & Sec.) | Option Ex | 16,328 | .00 | 0 |
2006-05-18 | Drakeman Donald L (President & Chief Executive) | Sale | 13,000 | 11.43 | 148,590 |
2006-05-17 | Drakeman Donald L (President & Chief Executive) | Sale | 275,000 | 11.31 | 3,110,250 |
2006-05-17 | Drakeman Donald L (President & Chief Executive) | Option Ex | 258,000 | 2.84 | 732,720 |
2006-04-19 | Drakeman Donald L (President & Chief Executive) | Option Ex | 40,000 | 3.22 | 128,800 |
2006-03-17 | Middlekauff W Bradford (SVP, General Counsel & Sec.) | Sale | 100,000 | 13.88 | 1,388,000 |
2006-03-17 | Middlekauff W Bradford (SVP, General Counsel & Sec.) | Option Ex | 100,000 | 6.37 | 637,000 |
2006-03-17 | Schaller Charles R | Sale | 15,000 | 14.00 | 210,000 |
Insider trading activities including stock purchases, stock sales, and option exercises of MEDX listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Medarex Inc (symbol MEDX, CIK number 874255) see the Securities and Exchange Commission (SEC) website.